





| Salt Composition: | Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg) |
| Manufacturer: | Franco-Indian Pharmaceuticals Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glyciphage-VG1 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. Glyciphage-VG1 Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Glyciphage-VG1 Tablet SR is a combination of three antidiabetic medicines:
What is Glyciphage-VG1 Tablet SR?
Glyciphage-VG1 Tablet SR contains Glimepiride, Metformin, and Voglibose. It's used to manage type 2 diabetes mellitus (DM). This medication improves blood glucose control in adults when combined with healthy diet and exercise. Glimepiride promotes insulin release from the pancreas. Metformin reduces glucose production by the liver and enhances insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that decreases postprandial (after meal) glucose levels. This combination is not suitable for type 1 diabetes treatment.
What are the possible side effects of Glyciphage-VG1 Tablet SR?
Common side effects may include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. It is important to report any unusual symptoms to your healthcare provider.
Are there any specific conditions in which Glyciphage-VG1 Tablet SR should not be taken?
Glyciphage-VG1 Tablet SR must not be used by patients with known allergies to the drug's ingredients or excipients. Use is also discouraged for those with moderate to severe kidney disease and inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Glyciphage-VG1 Tablet SR?
No, combining Glyciphage-VG1 Tablet SR with alcohol is not advised. It may lower blood sugar levels and increase the risk of lactic acidosis.
Can the use of Glyciphage-VG1 Tablet SR cause hypoglycemia?
Yes, Glyciphage-VG1 Tablet SR can contribute to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely if you miss meals, drink alcohol, exercise excessively, or take other antidiabetic medications together.
What are the instructions for storage and disposal of Glyciphage-VG1 Tablet SR?
Store Glyciphage-VG1 Tablet SR in its original packaging, tightly sealed. Follow the manufacturer's recommendations on label or packaging. Discard unused medication to prevent misuse. Ensure that it is not accessible to pets, children, and other unauthorized individuals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glyciphage-VG1 Tablet SR is to be taken empty stomach.
Alcohol
It is unsafe to consume alcohol with Glyciphage-VG1 Tablet SR.
Breastfeed
Glyciphage-VG1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glyciphage-VG1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby.